Inhibitory effects of epigallocatechin gallate on the propagation of bovine coronavirus in Madin-Darby bovine kidney cells

Animal Science Journal

Volumn 76, Issue 5, 2005, Pages 507-512

  Matsumoto, Mitsuyo ^a   Mukai, Takao ^a   Furukawa, Satoru ^b   Ohori, Hitoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Antiviral effect; Bovine coronavirus; Epigallocatechin gallate

Indexed keywords

BOVINAE; BOVINE CORONAVIRUS; CORONAVIRUS;

EID: 28144440913     PISSN: 13443941     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-0929.2005.00297.x     Document Type: Article

References (35)

1. Akashi H, Inaba Y, Miura Y, Tokuhisa S, Sato K, Satoda K. 1980. Properties of a coronavirus isolated from a cow with epizootic diarrhea. Veterinary Microbiology 5, 265-276.
2. Amarowicz R, Pegg R, Bautista DA. 2000. Antibacterial activity of green tea polyphenols against Escherichia coli K12. Die Nahrung 44, 60-62.
3. Chang L-K, Wei T-T, Chiu Y-F, Tung C-P, Chuang J-Y, Hung S-K, Li C, Liu S-T. 2003. Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate. Biochemical and Biophysical Research Communications 301, 1062-1068.
4. Chen L, Yang X, Jiao H, Zhao B. 2002. Tea catechins protect against lead-induced cytotoxicity, lipid peroxidation, and membrane fluidity in HepG2 cells. Toxicological Sciences 69, 149-156.
5. Clark MA. 1993. Bovine coronavirus. British Veterinary Journal 149, 51-70.
6. Freitag H, Wetzel H, Espenkoetter E. 1984. Prophylaxis of diarrhea due to rotavirus and coronavirus in calves. Tierarztliche Umschau 39, 731-734.
7. Haneda E, Furuya T, Asai S, Morikawa Y, Ohtsuki K. 2000. Biochemical characterization of casein responsible for stimulation of HIV-1 protease in vitro. Biochemical and Biophysical Research Communications 275, 434-439.
8. Hasoksuz M, Hoet AE, Loerch SC, Wittum TE, Nielsen PR, Saif LJ. 2002. Detection of respiratory and enteric shedding of bovine corona viruses in cattle in an Ohio feedlot. Journal of Veterinary Diagnostic Investigation 14, 308-313.
9. Heckert RA, Saif LJ, Myers GW. 1991. Mucosal and systemic isotype-specific antibody responses to bovine coronavirus structural proteins in naturally infected dairy calves. American Journal of Veterinary Research 52, 852-857.
10. Hirasawa M, Takada K. 2004. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. Journal of Antimicrobial Chemotherapy 53, 225-229.
11. Ikigai H, Nakane T, Hara Y, Shimamura T. 1993. Bactericidal catechins damage the lipid bilayer. Biochimica et Biophysica Acta 1147, 132-136.
12. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. 1996. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biology and Pharmaceutical Bulletin 19, 1518-1520.
13. Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y. 1985. Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor. Mutation Research 150, 127-132.
14. Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakage M, Hori N, Watanabe T, Takahashi K, Nagawa H. 2003. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. Journal of Allergy and Clinical Immunology 112, 951-957.
15. Kawase M, Wang R, Saijo T, Yagi K. 2000. Antioxidative activity of (-)-epigallocatechin-3-(3″-O-methyl) gallate isolated from fresh tea leaf and preliminary results on its biological activity. Bioscience, Biotechnology, and Biochemistry 64, 2218-2220.
16. Lai MMC, Cavanagh D. 1997. The molecular biology of coronavirus. Advances in Virus Research 48, 1-100.
17. Mebus CA, Stair EL, Rhodes MB, Twiehaus MJ. 1973. Neonatal calf diarrhea: Propagation, attenuation, and characteristics of a coronavirus-like agent. American Journal of Veterinary Research 34, 145-150.
18. Myers LL, Snodgrass DR. 1982. Colostral and milk antibody titers in cows vaccinated with a modified live-rotavirus-coronavirus vaccine. Journal of the American Veterinary Medical Association 181, 486-488.
19. Nakane H, Ono K. 1989. Differential inhibition of HIV-reverse transcriptase and various DNA and RNA polymerases by some catechin derivatives. Nucleic Acids Symposium Series 21, 115-116.
20. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. 1993. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Research 21, 289-299.
21. Nance CL, Shearer WT. 2003. Is green tea good for HIV-1 infection? Journal of Allergy and Clinical Immunology 112, 851-853.
22. Popova R, Zhang X. 2002. The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection. Virology 294, 222-236.
23. Sakanaka S, Okada Y. 2004. Inhibitory effect of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. Journal of Agricultural and Food Chemistry 52, 1688-1692.
24. Stein CA, Neckers LM, Nari BC, Mumbauer S, Hoke G, Pal R. 1991. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. Journal of Acquired Immune Deficiency Syndromes 4, 686-693.
25. Taniguchi S, Imayoshi Y, Kobayashi E, Takamatsu Y, Ito H, Hatano T, Sakagami H, Tokuda H, Nishino H, Sugita D, Shimura S, Yoshida T. 2002. Production of bioactive triterpenes by Eriobotrya japonica calli. Phytochemistry 59, 315-323.
26. Traven M, Naslund K, Linde N, Linde B, Silvan A, Fossum C, Hedlund KO, Larsson B. 2001. Experimental reproduction of winter dysentery in lactating cows using BCV comparison with BCV infection in milk-fed calves. Veterinary Microbiology 81, 127-151.
27. Waltner-Toews D, Martin SW, Meek AH, McMillan I, Crouch CF. 1985. A field trial to evaluate the efficacy of a combined rotavirus-coronavirus/Escherichia coli vaccine in dairy cattle. Canadian Journal of Comparative Medicine 49, 1-9.
28. Witvrouw M, De Clercq E. 1997. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. General Pharmacology 29, 497-511.
29. Wu H-Y, Guy JS, Yoo D, Vlasak R, Urbach E, Brian DA. 2003. Common RNA replication signals exist among group 2 coronaviruses: Evidence for in vivo recombination between animal and human coronavirus molecules. Virology 315, 174-183.
30. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. 2002. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Research 53, 19-34.
31. Yamaguchi K, Papp B, Zhang D, Ali AN, Agrawal S, Byrn RA. 1997. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1. AIDS Research and Human Retroviruses 13, 545-554.
32. Yee Y-K, Koo MW-L. 2000. Anti-Helicobacter pylori activity of Chinese tea: in vitro study. Alimentary Pharmacology and Therapeutics 14, 635-638.
33. Yen G-C, Chen H-Y. 1995. Antioxidant activity of various tea extracts in relation to their antimutagenicity. Journal of Agricultural and Food Chemistry 43, 27-32.
34. Yokozawa T, Cho EJ, Hara Y, Kitani K. 2000. Antioxidative activity of green tea treated with radical initiator 2,2′-azobis (2-amidinopropane) dihydrochloride. Journal of Agricultural and Food Chemistry 48, 5068-5073.
35. Zelus BD, Schickli JH, Blau DM, Weiss SR, Holmes KV. 2003. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37°C either by soluble murine CEACAM1 receptors or by pH 8. Journal of Virology 77, 830-840.